Open AccessFebuxostat as an effective drug of choice for urate-lowering therapy for gout (case report)
Author(s) -
И. Б. Башкова,
I. Madyanov
Publication year - 2022
Publication title -
medicinskij sovet
Language(s) - English
Resource type - Journals
eISSN - 2658-5790
pISSN - 2079-701X
DOI - 10.21518/2079-701x-2022-16-14-137-144
Subject(s) - febuxostat , gout , medicine , allopurinol , tolerability , uric acid , benzbromarone , hyperuricemia , renal function , surgery , adverse effect